The hypoxia, lactate and lactylation axis in lung disease: A metabolic and epigenetic framework.

IF 3.7 4区 医学 Q2 PATHOLOGY
Mingxing Wu, Wenhui Xu, Yimin Zhu
{"title":"The hypoxia, lactate and lactylation axis in lung disease: A metabolic and epigenetic framework.","authors":"Mingxing Wu, Wenhui Xu, Yimin Zhu","doi":"10.1016/j.prp.2026.156741","DOIUrl":null,"url":null,"abstract":"<p><p>Hypoxia accompanies diverse pulmonary diseases and can promote glycolytic reprogramming and lactate accumulation. Lactate serves as a metabolic fuel and signalling molecule and can supply substrates for protein lysine lactylation. These activities are related but experimentally distinct. Here, we evaluate a hypoxia, lactate and lactylation framework across pulmonary hypertension, lung cancer, pulmonary fibrosis, acute lung injury, chronic obstructive pulmonary disease and asthma. We distinguish studies that manipulate oxygen availability and measure downstream metabolic and lactylation responses from those that demonstrate lactate signalling or lactylation without establishing hypoxia as the initiating event. We assess evidence for individual mechanisms according to human validation, biochemical resolution and the specificity of in vivo interventions. This comparison identifies substantial gaps between an observed metabolic sequence and proof that a particular lactylation event mediates disease. We also examine how protein lactylation intersects with RNA-modifying enzymes and DNA-repair machinery, while recognizing that direct nucleic-acid lactylation remains unvalidated. Potential interventions range from lactate production and transport to lactylation regulators, but current agents frequently alter metabolism or other protein acylations. The framework therefore provides a basis for testing how oxygen stress influences pulmonary pathology rather than evidence for a uniformly established causal pathway or a clinically validated therapeutic class.</p>","PeriodicalId":19916,"journal":{"name":"Pathology, research and practice","volume":"289 ","pages":"156741"},"PeriodicalIF":3.7000,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pathology, research and practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.prp.2026.156741","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Hypoxia accompanies diverse pulmonary diseases and can promote glycolytic reprogramming and lactate accumulation. Lactate serves as a metabolic fuel and signalling molecule and can supply substrates for protein lysine lactylation. These activities are related but experimentally distinct. Here, we evaluate a hypoxia, lactate and lactylation framework across pulmonary hypertension, lung cancer, pulmonary fibrosis, acute lung injury, chronic obstructive pulmonary disease and asthma. We distinguish studies that manipulate oxygen availability and measure downstream metabolic and lactylation responses from those that demonstrate lactate signalling or lactylation without establishing hypoxia as the initiating event. We assess evidence for individual mechanisms according to human validation, biochemical resolution and the specificity of in vivo interventions. This comparison identifies substantial gaps between an observed metabolic sequence and proof that a particular lactylation event mediates disease. We also examine how protein lactylation intersects with RNA-modifying enzymes and DNA-repair machinery, while recognizing that direct nucleic-acid lactylation remains unvalidated. Potential interventions range from lactate production and transport to lactylation regulators, but current agents frequently alter metabolism or other protein acylations. The framework therefore provides a basis for testing how oxygen stress influences pulmonary pathology rather than evidence for a uniformly established causal pathway or a clinically validated therapeutic class.

肺部疾病的缺氧、乳酸和乳酸化轴:代谢和表观遗传框架。
缺氧伴随多种肺部疾病,可促进糖酵解重编程和乳酸积累。乳酸作为代谢燃料和信号分子,可以为蛋白质赖氨酸的乳酸化提供底物。这些活动是相关的,但在实验上是不同的。在这里,我们评估了肺动脉高压、肺癌、肺纤维化、急性肺损伤、慢性阻塞性肺疾病和哮喘的缺氧、乳酸和乳酸化框架。我们区分了那些操纵氧可用性和测量下游代谢和乳酸化反应的研究,以及那些没有将缺氧作为起始事件而证明乳酸信号或乳酸化的研究。我们根据人体验证、生化分辨率和体内干预的特异性来评估个体机制的证据。这种比较确定了观察到的代谢序列与特定的乳酸化事件介导疾病的证据之间的实质性差距。我们还研究了蛋白质乳酸化如何与rna修饰酶和dna修复机制相交,同时认识到直接核酸乳酸化仍然未经证实。潜在的干预范围从乳酸的产生和运输到乳酸化调节,但目前的药物经常改变代谢或其他蛋白质的酰化。因此,该框架为测试氧应激如何影响肺部病理提供了基础,而不是为统一建立的因果途径或临床验证的治疗类别提供证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.00
自引率
3.60%
发文量
405
审稿时长
24 days
期刊介绍: Pathology, Research and Practice provides accessible coverage of the most recent developments across the entire field of pathology: Reviews focus on recent progress in pathology, while Comments look at interesting current problems and at hypotheses for future developments in pathology. Original Papers present novel findings on all aspects of general, anatomic and molecular pathology. Rapid Communications inform readers on preliminary findings that may be relevant for further studies and need to be communicated quickly. Teaching Cases look at new aspects or special diagnostic problems of diseases and at case reports relevant for the pathologist''s practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书